The Good, the Bad, and the GVHD: Leveraging Targeted and Cellular Strategies to Improve Access to HCT and Post-transplant Outcomes

The Good, the Bad, and the GVHD: Leveraging Targeted and Cellular Strategies to Improve Access to HCT and Post-transplant Outcomes

The Good, the Bad, and the GVHD: Leveraging Targeted and Cellular Strategies to Improve Access to HCT and Post-transplant Outcomes

  • Provider:PVI, PeerView Institute for Medical Education
  • Activity Link: https://www.peerview.com/XRT
  • Start Date: 2025-02-14 06:00:00
  • End Date: 2025-02-14 06:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
    Nursing: 1.0 hours
  • Commercial Support: Source: Incyte Corporation - Amount: 64884.0 - Is Kind Support: False Source: Mallinckrodt Pharmaceuticals - Amount: 4806.0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.